OR WAIT 15 SECS
More pharma companies and regulators adopt technologies for remote quality audits and inspections.
FDA sticks with approved vaccine dosing regimen; supply agreements announced
Biopharma must deliver on COVID-19 vaccines and other promising therapies.
Annual employment survey reveals risks, rewards, and dedication.
FDA approval rate speeds up despite COVID-19 complications.
January 19, 2021
ReFIBE sterile cleanroom wipes are sustainable polyester wipes made from recycled post-consumer plastic bottles.
Since FDA authorization of two innovative mRNA vaccines to combat COVID-19 in late 2020, 30 million doses have been distributed, but only 4 million people were vaccinated in December 2020, and just 13 million have received shots so far.
The CPhI event, which was originally scheduled for Aug. 31–Sept. 2, 2021 at the Fiera Milano in Milan, Italy, will be rescheduled for Nov. 9–11, 2021 at the same venue.
The new US offices will give the company the ability to support its US-based customers on site while continuing to collaborate with its global team.
January 18, 2021
Henogen will be integrated into Thermo Fisher’s Pharma Services business within its Laboratory Products and Services segment.
The 40,000-ft.2 facility will feature eight cleanrooms with configurations for the production of cell and viral vector products.
January 15, 2021
This new agreement covers 1.25 million additional doses of the antibody cocktail containing casirivimab and imdevimab for the treatment of COVID-19.
The collaboration will focus on up to three types of lung and gastrointestinal cancers.
The first four investments of the new program will support clinical-stage biotechnology companies while new investments will include companies focused on oncology, rare disease, and inflammation and immunology.
The acquisition significantly expands Precision Medicine Group’s cell and gene therapy expertise.